Sugi Predict

Sugi Predict / Compounds / SCHEMBL1481600

SCHEMBL1481600

SCHEMBL1481600

CCn1cc(-c2ccc(OC)cc2)nc1/C=C/c1ccc(-c2ccc(OCCCC(=O)O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ PPARA Q07869 3/20 0.49
▸ FFAR1 O14842 2/20 0.49
▸ PPARG P37231 1/20 0.49
▸ PPARD Q03181 1/20 0.49
▸ LTB4R Q15722 2/20 0.45
▸ FFAR4 Q5NUL3 1/20 0.44
▸ HDAC3 O15379 2/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC7 Q8WUI4 2/20 0.43
▸ HDAC2 Q92769 2/20 0.43
▸ HDAC10 Q969S8 2/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC9 Q9UKV0 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1481604 1.00 CASP3 (0.50) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481721 0.93 PPARA (0.52) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481717 0.93 PPARA (0.52) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481817 0.91 AGER (0.49) CASP3SENP8SENP7SENP6PPARA
SCHEMBL12754209 0.91 RARB (0.47) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481819 0.91 AGER (0.49) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481429 0.91 HDAC6 (0.45) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481426 0.91 HDAC6 (0.45) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481325 0.91 MMP2 (0.50) CASP3SENP8SENP7SENP6PPARA
SCHEMBL1481323 0.91 MMP2 (0.50) CASP3SENP8SENP7SENP6PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 — — US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 — — US disclosed
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents TRANSTECH PHARMA, INC. (US) 2011-03-31 — — US disclosed
WO-2004071447-A9 SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS TRANSTECH PHARMA INC (US) 2005-10-13 — — WO disclosed
US-20040192743-A1 Substituted azole derivatives as therapeutic agents TRANSTECH PHARMA, INC. 2004-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192743-A1 Substituted azole derivatives as therapeutic agents PTPRS, PTPRO, PTPRJ CASP3 3544/4885SENP8 3559/4885SENP7 3365/4885
US-20110077399-A1 Substituted Azole Derivatives as Therapeutic Agents PTPRS, PTPRO, PTPRJ CASP3 3544/4885SENP8 3559/4885SENP7 3365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.